Microarray Gene Expression Data from Early Skin Biopsies of a Secukinumab Clinical Trial in Psoriasis

Request Access

IL-17A inhibition by secukinumab induces early clinical, histopathological, and molecular resolution of psoriasis.

J. Krueger, K. Wharton, T. Schlitt, et al.. (2019). The Journal of allergy and clinical immunology. Cited 161 times. https://doi.org/10.1016/j.jaci.2019.04.029
NCPI Dataset Catalog
Feedback & Support
v0.9.0-d9e5747